| Date Filed | Type | Description |
| 05/31/2023 |
4
| Stacey Jennifer Evans (Director) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.87, valued at
$21.8k
|
|
| 02/28/2023 |
4
| Stacey Jennifer Evans (See Remarks) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $1.78, valued at
$240.3k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2021 |
3
| Stacey Jennifer Evans (Director) has filed a Form 3 on Context Therapeutics Inc. |
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/01/2015 |
4
| Stacey Jennifer Evans (SVP, General Counsel & Secty) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Paid exercise price by delivering 2,469 shares
@ $2.18, valued at
$5.4k
Granted 70,239 shares
@ $0
Granted 142,550 options to buy
@ $2.18, valued at
$310.8k
|
|
| 03/12/2015 |
4
| Stacey Jennifer Evans (SVP, General Counsel & Secty) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Granted 47,000 options to buy
@ $2.62, valued at
$123.1k
|
|
| 06/02/2014 |
4
| Stacey Jennifer Evans (SVP, General Counsel & Secty) has filed a Form 4 on ANTARES PHARMA, INC.|
Txns:
| Granted 48,544 shares
@ $0
Granted 24,272 shares
@ $0
Granted 100,000 options to buy
@ $3.09, valued at
$309k
|
|
| 04/04/2011 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 941 shares
@ $22.47, valued at
$21.1k
|
|
| 02/22/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2010 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC|
Txns:
| Granted 9,378 shares
@ $0
Granted 35,000 options to buy
@ $30.2, valued at
$1.1M
|
|
| 09/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/28/2009 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 04/30/2009 |
4/A
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 03/03/2009 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 02/27/2009 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 01/21/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 01/08/2009 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 12/22/2008 |
4
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |
| 12/22/2008 |
4/A
| Stacey Jennifer Evans (Executive VP & General Counsel) has filed a Form 4 on AUXILIUM PHARMACEUTICALS INC |